feed,title,long_url,short_url
Benzinga,FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients,https://benzinga.com/general/biotech/24/02/37239599/fda-approves-johnson-johnsons-reduced-tecvayli-dosing-in-pretreated-multiple-myeloma-patients,https://da.gd/pdi21t
Benzinga,Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?,https://benzinga.com/analyst-ratings/analyst-color/24/02/37239400/why-is-cancer-genetics-test-focused-neogenomics-stock-trading-higher-today,https://da.gd/P905jo
